CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 220 enrolled
Drug / intervention
Dialysisprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04218370
NCT04218370N/ACompleted
CompareCT.gov

LIBERation From AcuTE Dialysis

University of California, San Francisco·interventional·Posted Jan 6, 2020·Updated Dec 9, 2025

In Brief

A clinical study evaluating Dialysis for Acute Kidney Injury and 2 related conditions. Completed, enrolled 220 participants across 4 sites.

Detailed Summary

The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge for how to guide delivery of dialysis to facilitate renal recovery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury, Kidney; Disease, Acute, Dialysis Related Complication
CountriesUnited States
CollaboratorsVanderbilt University Medical Center, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 6, 2020
Enrollment StartJan 23, 2020
Primary CompletionJun 8, 2025
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 6.5 years ago

Interventions

Dialysisprocedure

Dialysis treatment, either in the form of hemodialysis or continuous renal replacement therapy (if patient develops hemodynamic instability)